The University of Colorado Anschutz Medical Campus is the academic health sciences campus in Aurora, Colorado that houses the University of Colorado's six health sciences-related schools and colleges, ...

During the past decade, University of Colorado - Anschutz Medical Campus conducted 310 clinical trials. In the 10-year time frame, 310 clinical trials started and 84 clinical trials were completed, i.e. on average, 27.1% percent of trials that started reached the finish line to date. In the past 5 years, 193 clinical trials started and 53 clinical trials were completed. i.e. 27.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado - Anschutz Medical Campus" #1 sponsor was "University of Colorado, Denver" with 228 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 13 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "Gilead Sciences" with 6 trials sponsored. Other sponsors include 192 different institutions and companies that sponsored additional 156 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado - Anschutz Medical Campus" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 25 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator, "National Institute on Aging (NIA)" with 11 trials as a collaborator, "University of Colorado, Denver" with 11 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 10 trials as a collaborator. Other collaborators include 256 different institutions and companies that were collaborators in the rest 185 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado - Anschutz Medical Campus" are "Obesity" (31 trials), "HIV Infections" (12 trials), "Type 2 Diabetes" (10 trials), "Aging" (9 trials) and "Endothelial Dysfunction" (7 trials). Many other conditions were trialed in "University of Colorado - Anschutz Medical Campus" in a lesser frequency.

Most popular intervention types in "University of Colorado - Anschutz Medical Campus" are "Drug" (225 trials), "Other" (80 trials), "Behavioral" (76 trials), "Device" (35 trials) and "Biological" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (66 trials), "Exercise" (6 trials), "Paclitaxel" (5 trials), "Control" (4 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado - Anschutz Medical Campus" are 404 trials for "All" genders, 41 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are 191 active trials in "University of Colorado - Anschutz Medical Campus". 7 are not yet recruiting, 135 are recruiting, 41 are Active, not recruiting, and 8 are Enrolling by invitation. In total, there were 207 completed trials in University of Colorado - Anschutz Medical Campus, 2 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado - Anschutz Medical Campus, 60 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 20 trials, and there were also 147 trials that are defined as “Not Applicable".

University of Colorado - Anschutz Medical Campus has several departments that took part in Clinical trials: "University of Colorado Cancer Center" - 538 trials, "Barbara Davis Center for Childhood Diabetes" - 147 trials, "University of Colorado; Anschutz Medical Campus Department of Neurology" - 7 trials, "University of Colorado School of Dental Medicine" - 6 trials, "University of Colorado; dept of ophthalmology" - 6 trials, "University of Colorado School of Medicine: Division of Rheumatology" - 5 trials, "University of Colorado, Hip Preservation Center, Orthopedic Department" - 3 trials, "ATTN-Research Pharmacist" - 3 trials, "University of Colorado Cancer Center Department of Hematology" - 3 trials, "Denver Nephrology Research" - 2 trials, "Transplant Center And Hepatology Clinic, B-154" - 2 trials, "University Of Colorado Department of Obstetrics & Gyncology" - 2 trials, "DRUG SHIPMENT: University of Colorado Cancer Center" - 2 trials, "University of Colorado, School of Medicine - Hepatology Clinic - Anschutz" - 2 trials, "University of Colorado Denver - Division of Pulmonary Sciences" - 2 trials, "Project Safe" - 2 trials